What is the recommended insulin therapy for women with type 2 diabetes in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Therapy for Type 2 Diabetes in Pregnancy

Insulin is the preferred and first-line pharmacologic treatment for type 2 diabetes in pregnancy, as it does not cross the placenta and provides the safest option for both mother and fetus. 1

Initial Management Before Insulin

Before starting insulin, begin with medical nutrition therapy, physical activity, and weight management, with minimum daily requirements of 175g carbohydrate, 71g protein, and 28g fiber. 1 Target weight gain of 15-25 lb for overweight women and 10-20 lb for obese women—never recommend weight loss during pregnancy due to increased risk of small-for-gestational-age infants. 1

When to Initiate Insulin

Start insulin when lifestyle modifications fail to maintain glycemic targets or when signs of excessive fetal growth appear. 2 Glycemic control is often easier to achieve in type 2 diabetes than type 1 diabetes, but may require much higher insulin doses, sometimes necessitating concentrated insulin formulations. 3

Glycemic Targets

Achieve the following blood glucose goals through frequent monitoring (4-6 times daily): 1, 4

  • Fasting glucose: 70-95 mg/dL
  • One-hour postprandial: 110-140 mg/dL
  • Two-hour postprandial: 100-120 mg/dL
  • A1C target: <6% to <7% (42-53 mmol/mol), individualized to avoid hypoglycemia

Insulin Regimen and Dosing

Use multiple daily injections with a basal-bolus regimen or insulin pump technology. 1 Both delivery methods are acceptable, with neither demonstrating superiority over the other. 2

Expect insulin requirements to increase dramatically: Doses will approximately double by the third trimester, with linear increases of about 5% per week starting around 16 weeks gestation. 1 This differs from type 1 diabetes where requirements may initially decrease in the first trimester. 4

FDA-Approved Insulin Types

The FDA has approved insulin lispro, insulin aspart, and insulin detemir for use in pregnancy, with published studies showing no association with major birth defects, miscarriage, or adverse maternal or fetal outcomes. 2, 5 These rapid-acting analogs improve postprandial glucose control and are considered safe and effective. 6, 7

Role of Metformin (Not First-Line)

Metformin may be considered as adjunctive therapy to insulin only, not as monotherapy, due to lack of long-term safety data. 1 One randomized controlled trial found that adding metformin to insulin resulted in less maternal weight gain and fewer cesarean births and macrosomic neonates, but there was a doubling of small-for-gestational-age neonates. 3 The American Diabetes Association does not recommend metformin as first-line therapy due to concerns about long-term offspring safety and failure to provide adequate glycemic control in 25-28% of women. 2

Critical Safety Measures

Hypoglycemia Prevention

Provide comprehensive education to patients and family members on hypoglycemia prevention, recognition, and treatment before, during, and after pregnancy, as counter-regulatory responses are altered in pregnancy. 1, 4 Glucagon should be available and close contacts trained in its use. 8

Preeclampsia Prevention

Prescribe low-dose aspirin 100-150 mg daily (not the standard 81 mg, which is ineffective) starting at 12-16 weeks gestation to reduce preeclampsia risk. 3, 1, 2 A dosage of 162 mg/day may be suggested to reduce risk of uncontrolled maternal hypertension. 3

Medication Discontinuation

Immediately discontinue ACE inhibitors, angiotensin receptor blockers, and statins at conception due to fetal risks including renal dysplasia, oligohydramnios, pulmonary hypoplasia, and intrauterine growth restriction. 3, 1

Monitoring and Titration

Evaluate insulin requirements every 2-3 weeks as pregnancy progresses, with more frequent adjustments based on blood glucose patterns, carbohydrate intake, physical activity, and gestational age. 4, 2 Continuous glucose monitoring can improve glycemic control and reduce hypoglycemia risk. 2

Postpartum Management

After delivery, insulin requirements drop dramatically. 3 Reduce insulin to 50% of end-pregnancy doses or 80% of pre-pregnancy doses immediately after delivery, and monitor closely for hypoglycemia, especially during breastfeeding. 1

Specialized Care Referral

Refer to a specialized center offering team-based care (including maternal-fetal medicine specialist, endocrinologist experienced in managing pregnancy with preexisting diabetes, dietitian, nurse, and social worker) due to the complexity of insulin management in pregnancy. 3, 1, 4

References

Guideline

Management of Type 2 Diabetes in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insulin Therapy During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Management in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of diabetes in pregnancy.

The Journal of the Association of Physicians of India, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.